000 01461 a2200421 4500
005 20250514162005.0
264 0 _c20040629
008 200406s 0 0 eng d
022 _a1043-4666
024 7 _a10.1016/j.cyto.2003.08.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aO'Connor, Kevin A
245 0 0 _aFurther characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects.
_h[electronic resource]
260 _bCytokine
_cDec 2003
300 _a254-65 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aCentral Nervous System
_xdrug effects
650 0 4 _aCentral Nervous System Agents
_xpharmacology
650 0 4 _aFever
_xmetabolism
650 0 4 _aHMGB1 Protein
_xpharmacology
650 0 4 _aHypothalamus
_xdrug effects
650 0 4 _aInflammation
_xmetabolism
650 0 4 _aInterleukin-1
_xmetabolism
650 0 4 _aRats
700 1 _aHansen, Michael K
700 1 _aRachal Pugh, C
700 1 _aDeak, Molly M
700 1 _aBiedenkapp, Joseph C
700 1 _aMilligan, Erin D
700 1 _aJohnson, John D
700 1 _aWang, Haichao
700 1 _aMaier, Steven F
700 1 _aTracey, Kevin J
700 1 _aWatkins, Linda R
773 0 _tCytokine
_gvol. 24
_gno. 6
_gp. 254-65
856 4 0 _uhttps://doi.org/10.1016/j.cyto.2003.08.001
_zAvailable from publisher's website
999 _c14347056
_d14347056